Norlyda
NORLYDA™ (norethindrone tablets, USP) 0.35 mg Rx only Patients should be counseled that oral contraceptives do not protect against transmission of HIV (AIDS) and other sexually transmitted diseases (STDs) such as Chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis.
Approved
Approval ID
d692cf63-803d-42b5-81fe-536a94b41146
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 13, 2021
Manufacturers
FDA
A-S Medication Solutions
DUNS: 830016429
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
norethindrone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code50090-3235
Application NumberANDA202260
Product Classification
M
Marketing Category
C73584
G
Generic Name
norethindrone
Product Specifications
Effective DateMay 17, 2019
FDA Product Classification